Successful treatment of pachyonychia congenita with simvastatin
Author | Iqneibi, Mariam |
Author | Al-Khawaga, Sara |
Author | Wafi, Omar |
Author | Steinhoff, Martin |
Available date | 2024-12-24T11:03:42Z |
Publication Date | 2023-11-22 |
Publication Name | Journal of the European Academy of Dermatology and Venereology |
Identifier | http://dx.doi.org/10.1111/jdv.19630 |
Citation | Iqneibi, M., Al‐Khawaga, S., Wafi, O., & Steinhoff, M. (2024). Successful treatment of pachyonychia congenita with simvastatin. Journal of the European Academy of Dermatology and Venereology, 38(4), e356-358. |
ISSN | 0926-9959 |
Abstract | Pachyonychia congenita (PC) is a rare autosomal-dominant genodermatosis. It is an ectodermal, dysplastic disorder of keratinization that typically arises at birth or early infancy due to keratin-specific gene mutations, including mutations in KRT6A, KRT6B, KRT6C, KRT16 and KRT17 has a myriad of presentations, the most notable features of which includes nail dystrophy and dyskeratosis of the skin (palmoplantar hyperkeratosis) and mucous membrane changes (leukokeratosis). The latter clinical features were better identified by Jadassohn and Lewandowsky in 1906 as an addition to Muller's findings in 1904. |
Language | en |
Publisher | John Wiley and Sons |
Subject | leukokeratosis palmoplantar hyperkeratosis |
Type | Other |
Issue Number | 4 |
Volume Number | 38 |
ESSN | 1468-3083 |
Files in this item
This item appears in the following Collection(s)
-
Medicine Research [1548 items ]